Pavlovian Conditioned Approach, Sign-tracking, average lever latency on days 4 and 5 of testing
Tags: Behavior · Learning and memory · Pavlovian conditioned approach
Project: p50_shelly_flagel_2014
0 loci · 0 genes with independent associations · 0 total associated genes
# | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
---|
Trait | Chi2 ratio | # genes+ | # genes++ | % genes++ | Corr | Corr P | Genes |
---|
Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 0 | 0 | 1.22 |
Adipose | alternative TSS | 0 | 0 | 1.33 |
Adipose | gene expression | 0 | 0 | 1.27 |
Adipose | isoform ratio | 0 | 0 | 1.28 |
Adipose | intron excision ratio | 0 | 0 | 1.21 |
Adipose | mRNA stability | 0 | 0 | 1.26 |
BLA | alternative polyA | 0 | 0 | 1.32 |
BLA | alternative TSS | 0 | 0 | 1.28 |
BLA | gene expression | 0 | 0 | 1.24 |
BLA | isoform ratio | 0 | 0 | 1.36 |
BLA | intron excision ratio | 0 | 0 | 1.42 |
BLA | mRNA stability | 0 | 0 | 1.22 |
Brain | alternative polyA | 0 | 0 | 1.18 |
Brain | alternative TSS | 0 | 0 | 1.31 |
Brain | gene expression | 0 | 0 | 1.26 |
Brain | isoform ratio | 0 | 0 | 1.29 |
Brain | intron excision ratio | 0 | 0 | 1.34 |
Brain | mRNA stability | 0 | 0 | 1.24 |
Eye | alternative polyA | 0 | 0 | 1.33 |
Eye | alternative TSS | 0 | 0 | 1.48 |
Eye | gene expression | 0 | 0 | 1.29 |
Eye | isoform ratio | 0 | 0 | 1.34 |
Eye | intron excision ratio | 0 | 0 | 1.22 |
Eye | mRNA stability | 0 | 0 | 1.45 |
IL | alternative polyA | 0 | 0 | 1.15 |
IL | alternative TSS | 0 | 0 | 1.46 |
IL | gene expression | 0 | 0 | 1.23 |
IL | isoform ratio | 0 | 0 | 1.44 |
IL | intron excision ratio | 0 | 0 | 1.46 |
IL | mRNA stability | 0 | 0 | 1.22 |
LHb | alternative polyA | 0 | 0 | 1.24 |
LHb | alternative TSS | 0 | 0 | 1.49 |
LHb | gene expression | 0 | 0 | 1.28 |
LHb | isoform ratio | 0 | 0 | 1.4 |
LHb | intron excision ratio | 0 | 0 | 1.53 |
LHb | mRNA stability | 0 | 0 | 1.24 |
Liver | alternative polyA | 0 | 0 | 1.2 |
Liver | alternative TSS | 0 | 0 | 1.33 |
Liver | gene expression | 0 | 0 | 1.21 |
Liver | isoform ratio | 0 | 0 | 1.19 |
Liver | intron excision ratio | 0 | 0 | 1.17 |
Liver | mRNA stability | 0 | 0 | 1.18 |
NAcc | alternative polyA | 0 | 0 | 1.19 |
NAcc | alternative TSS | 0 | 0 | 1.19 |
NAcc | gene expression | 0 | 0 | 1.23 |
NAcc | isoform ratio | 0 | 0 | 1.34 |
NAcc | intron excision ratio | 0 | 0 | 1.39 |
NAcc | mRNA stability | 0 | 0 | 1.23 |
OFC | alternative polyA | 0 | 0 | 1.19 |
OFC | alternative TSS | 0 | 0 | 1.44 |
OFC | gene expression | 0 | 0 | 1.25 |
OFC | isoform ratio | 0 | 0 | 1.49 |
OFC | intron excision ratio | 0 | 0 | 1.49 |
OFC | mRNA stability | 0 | 0 | 1.28 |
PL | alternative polyA | 0 | 0 | 1.24 |
PL | alternative TSS | 0 | 0 | 1.34 |
PL | gene expression | 0 | 0 | 1.25 |
PL | isoform ratio | 0 | 0 | 1.31 |
PL | intron excision ratio | 0 | 0 | 1.37 |
PL | mRNA stability | 0 | 0 | 1.24 |